Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-27

Clinical Trial Update: EndeavorOTC™ Prospective Product Registry

View source ↗

Summary

An update on the EndeavorOTC prospective product registry for attention-deficit/hyperactivity disorder, sponsored by Akili Interactive Labs, with status active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EndeavorOTC

Snippet

Sponsor: Akili Interactive Labs, Inc. | Conditions: ADHD | Status: ACTIVE_NOT_RECRUITING